CryoPort, Inc. (CYRX.OB) announced that the company has successfully shipped stem cells from Southern California to Australia through the use of the CryoPort Express Shipper.
Celprogen’s CEO, Jay Sharma, commented, “The CryoPort Express shipper has provided a more secure, cost-effective alternative to dry ice as we ship our stem cell research and therapeutic products to customers around the world. In addition to Australia, we have successfully utilized the CryoPort Express shipper for shipments to many diverse locations, such as South Africa, Japan, United Kingdom and Germany and have found the extra holding time an important hedge against delays that may result from regulatory and custom holds.”
Peter Berry, CEO of CryoPort, added, “We are pleased to be able to address the challenges that biotechnology companies such as Celprogen confront as they ship high value biomaterials in the global cold chain. These successful shipments reinforce the value of the CryoPort Express business model in both Europe and the developing world.”
Let us hear your thoughts below: